Southern RNA is an Australian-based company recognized as an expert in developing and manufacturing pharmaceutical ingredients. The company specializes in producing nucleic acid products that support the clinical development of therapeutic products. Their suite of reagents and services, tailored for RNA-based therapeutics and vaccines, including their flagship mRNA capping reagent, Co Cap® A, which aims to empower clients to pioneer the next wave of medicinal breakthroughs with the highest quality reagents.